top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Ischemic Heart Disease in the Context of Different Comorbidities
Ischemic Heart Disease in the Context of Different Comorbidities
Autore Costache Irina-Iuliana
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (242 p.)
Soggetto topico Medicine
Cardiovascular medicine
Soggetto non controllato coronary artery disease
ischemic heart disease
atherosclerosis
genetic risk factors
heritability
polymorphism
GWAS
PRS
COVID-19
myocardial ischemia
electrocardiography
accelerated atherosclerosis
coronary spasm
coronary thrombosis
endothelial dysfunction
cancer
prevention
radiotherapy
chemotherapy
liver cirrhosis
prevalence
liver transplantation
treatment
myocardial injury
cytokines
biomarkers
heart failure
left ventricular remodeling
myocardial infarction
wall stress
inflammation
neurohormonal activation
inflammatory bowel disease
ulcerative colitis
Crohn's disease
cardiovascular risk
frailty
chronic coronary syndrome
elderly
acute coronary syndrome
carbon monoxide poisoning
severity of poisoning
cardiotoxicity
troponin
cardiac dysfunction
non-alcoholic fatty liver disease
liver-heart axis
ISBN 3-0365-5809-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910637784603321
Costache Irina-Iuliana  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacogenetics to Avoid Adverse Drug Reactions
Pharmacogenetics to Avoid Adverse Drug Reactions
Autore López-Fernández Luis A
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (220 p.)
Soggetto topico Medicine
Soggetto non controllato 5-fluorouracil
capecitabine
fluoropyrimidine
thymidylate synthase
thymidylate synthase enhancer region
upstream stimulatory factor 1
adverse drug reactions
pharmacogenomics
epistasis
random forest
statin
cardiovascular disease
colorectal cancer
personalised medicine
toxicity
(es)citalopram
drug-gene-interaction
drug-drug-interaction
drug-drug-gene-interaction
the PharmLines initiative
antipsychotic agents
pharmacogenetics
cytochrome P-450 enzyme system
psychotic disorders
precision medicine
direct oral anticoagulants
clinical implementation
atorvastatin
SLCO1B1
HLA
cutaneous adverse drug reaction
SCAR
genetic polymorphism
antiepileptics
CYP450 enzymes
platelet reactivity
single-nucleotide variants
acute coronary syndrome
clopidogrel
genotype
allele
polymorphism
HLA B
CYP2C9*3
cutaneous adverse drug reactions (CADRs)
anti-epileptic drugs (AEDS)
phenytoin (PHT)
genetic risk factors
South India
India
cardiology
adverse events
guidelines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557610103321
López-Fernández Luis A  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui